Diabetes
MicroCHIPS Names Tamborlane to New Scientific Advisory Board
Published in Drug Law Weekly, October 7th, 2008
The scientific advisory board will support MicroCHIPS in its development of next-generation biosensing and drug delivery devices to increase therapeutic control and effectiveness for people with diabetes, osteoporosis and other debilitating diseases. The company's lead program is a long-term implanted continuous glucose monitoring device using the company's patented microreservoir technologies.
Dr. Tamborlane is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-10-07)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Hospital residents report patient-handoff problems common, can lead to patient harm - American Council of Engineering Companies ACEC
ACEC Urges Congress to Address Infrastructure Crisis in Bailout Package - Antibiotics
Researchers from Mayo Clinic detail new studies and findings in the area of antibiotics - ARIAD Pharmaceuticals, Inc.
ARIAD Announces Court Rulings Regarding NF-kappaB Patent Lawsuit with Amgen - Arizona BioIndustry Association
AZBio Announces 2008 Award Winners - BioJapan 2008
Latest Biotechnologies Gather From More Than 23 Countries at BioJapan 2008 - World Business Forum - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
